Michael W. Pariza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Michael W. Pariza has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Yeonhwa Park
Food Research Institute, Department of Food Microbiology and Toxicology, University of Wisconsin-Madison, Madison, WI 53706
9 shared publicationsMark E. Cook
5 shared publicationsJayne M. Storkson
Food Research Institute, Department of Food Microbiology and Toxicology University of Wisconsin‐Madison 1925 Willow Dr. Madison Wisconsin 53706
3 shared publicationsKaren J. Albright
Food Research Institute, Department of Food Microbiology and Toxicology University of Wisconsin‐Madison 1925 Willow Dr. Madison Wisconsin 53706
3 shared publicationsWei Liu
Food Research Institute, Department of Food Microbiology and Toxicology University of Wisconsin‐Madison 1925 Willow Dr. Madison Wisconsin 53706
3 shared publicationsEric A. Johnson
1 shared publication
Latest Publications
- Open Access
- 1 March 2003
- Published by Oxford University Press (OUP) in The Journal of Nutrition
- Vol. 133 (3) , 663-667
Short-Term Intake of Conjugated Linoleic Acid Inhibits Lipoprotein Lipase and Glucose Metabolism but Does Not Enhance Lipolysis in Mouse Adipose Tissue1
Feeding diets supplemented with t10c12 conjugated linoleic acid (CLA) to growing mice reduces body fat mass. The effects are evident after 1 wk and maximal by 3 wk and are accompanied by reductions in fat cell size. This may complicate direct comparisons with adipocytes from control mice. Accordingly, we investigated the early biochemical events that occur within adipocytes during the first week of CLA feeding, before changes in the size of adipocytes have occurred. Female ICR mice were fed a control diet or a diet supplemented with 0.5 g/100 g of CLA for 4 d, at which time there were no differences in body weight, fat mass or adipocyte size (except that CLA-fed mice had fewer adipocytes >90 μm in diameter). Parametrial adipose tissue from the CLA-fed mice had significantly reduced heparin-releasable lipoprotein lipase (LPL) and intracellular LPL activities and significantly reduced glucose incorporation into CO2, fatty acid and glycerol. There were no differences between adipose tissues from CLA-fed or control mice in the ratios of 16:0 to 16:1 and 18:0 to 18:1 fatty acids or in norepinephrine-stimulated lipolysis. Serum insulin levels in food-deprived mice, measured at 4 d and 7 wk, did not differ between groups nor did the concentration of free fatty acids in serum of food-deprived or fed mice measured at the same time points. In mice, CLA-induced inhibition of heparin-releasable LPL and glucose metabolism may be the most important early steps leading to subsequent body fat reduction. In addition, CLA does not appear to enhance lipolysis in mouse adipose tissue in vivo.
- 1 March 2003
- Published by Oxford University Press (OUP) in The Journal of Nutrition
- Vol. 133 (3) , 663-667
Open AccessShort-Term Intake of Conjugated Linoleic Acid Inhibits Lipoprotein Lipase and Glucose Metabolism but Does Not Enhance Lipolysis in Mouse Adipose Tissue1
Feeding diets supplemented with t10c12 conjugated linoleic acid (CLA) to growing mice reduces body fat mass. The effects are evident after 1 wk and maximal by 3 wk and are accompanied by reductions in fat cell size. This may complicate direct comparisons with adipocytes from control mice. Accordingly, we investigated the early biochemical events that occur within adipocytes during the first week of CLA feeding, before changes in the size of adipocytes have occurred. Female ICR mice were fed a control diet or a diet supplemented with 0.5 g/100 g of CLA for 4 d, at which time there were no differences in body weight, fat mass or adipocyte size (except that CLA-fed mice had fewer adipocytes >90 μm in diameter). Parametrial adipose tissue from the CLA-fed mice had significantly reduced heparin-releasable lipoprotein lipase (LPL) and intracellular LPL activities and significantly reduced glucose incorporation into CO2, fatty acid and glycerol. There were no differences between adipose tissues from CLA-fed or control mice in the ratios of 16:0 to 16:1 and 18:0 to 18:1 fatty acids or in norepinephrine-stimulated lipolysis. Serum insulin levels in food-deprived mice, measured at 4 d and 7 wk, did not differ between groups nor did the concentration of free fatty acids in serum of food-deprived or fed mice measured at the same time points. In mice, CLA-induced inhibition of heparin-releasable LPL and glucose metabolism may be the most important early steps leading to subsequent body fat reduction. In addition, CLA does not appear to enhance lipolysis in mouse adipose tissue in vivo.
- 1 June 2002
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 4 (3) , 335-338
Conjugated Linoleic Acid May Be Useful in Treating Diabetes by Controlling Body Fat and Weight Gain
- 1 June 2002
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 4 (3) , 335-338
Conjugated Linoleic Acid May Be Useful in Treating Diabetes by Controlling Body Fat and Weight Gain
- 17 October 2001
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1534 (1) , 27-33
Lipoxygenase inhibitors inhibit heparin-releasable lipoprotein lipase activity in 3T3-L1 adipocytes and enhance body fat reduction in mice by conjugated linoleic acid
- 17 October 2001
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1534 (1) , 27-33
Lipoxygenase inhibitors inhibit heparin-releasable lipoprotein lipase activity in 3T3-L1 adipocytes and enhance body fat reduction in mice by conjugated linoleic acid
- Top Cited Papers
- 1 July 2001
- Published by Elsevier in Progress in Lipid Research
- Vol. 40 (4) , 283-298
The biologically active isomers of conjugated linoleic acid
- 1 July 2001
- Published by Elsevier in Progress in Lipid Research
- Vol. 40 (4) , 283-298
Top Cited PapersThe biologically active isomers of conjugated linoleic acid
- 1 April 2001
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 33 (2) , 173-186
Evaluating the Safety of Microbial Enzyme Preparations Used in Food Processing: Update for a New Century
- 1 April 2001
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 33 (2) , 173-186
Evaluating the Safety of Microbial Enzyme Preparations Used in Food Processing: Update for a New Century
- 1 January 2000
- Published by Wiley in Proceedings of the Society for Experimental Biology and Medicine
- Vol. 223 (1) , 8-13
Mechanisms of Action of Conjugated Linoleic Acid: Evidence and Speculation
- 1 January 2000
- Published by Wiley in Proceedings of the Society for Experimental Biology and Medicine
- Vol. 223 (1) , 8-13
Mechanisms of Action of Conjugated Linoleic Acid: Evidence and Speculation
- 1 January 2000
- Published by Wiley in Proceedings of the Society for Experimental Biology and Medicine
- Vol. 223 (1) , 8-13
Mechanisms of Action of Conjugated Linoleic Acid: Evidence and Speculation
Conjugated linoleic acid (CLA) has been shown to inhibit carcinogenesis and atherosclerosis, enhance immunologic function while protecting against the catabolic effects of immune stimulation, affect body composition change (reducing body fat gain while enhancing lean body mass gain), and stimulate the growth of young rats. We discuss possible biochemical mechanisms that underlie these physiological effects. We emphasize the importance of considering the effects, both individually and combined, of the two CLA isomers (cis-9, trans-11 CLA and trans-10, cis-12 CLA) that have been shown to exhibit biological activity and which appear to exert their effects via different biochemical mechanisms.
- 1 January 2000
- Published by Wiley in Proceedings of the Society for Experimental Biology and Medicine
- Vol. 223 (1) , 8-13
Mechanisms of Action of Conjugated Linoleic Acid: Evidence and Speculation
Conjugated linoleic acid (CLA) has been shown to inhibit carcinogenesis and atherosclerosis, enhance immunologic function while protecting against the catabolic effects of immune stimulation, affect body composition change (reducing body fat gain while enhancing lean body mass gain), and stimulate the growth of young rats. We discuss possible biochemical mechanisms that underlie these physiological effects. We emphasize the importance of considering the effects, both individually and combined, of the two CLA isomers (cis-9, trans-11 CLA and trans-10, cis-12 CLA) that have been shown to exhibit biological activity and which appear to exert their effects via different biochemical mechanisms.
- Open Access
- 1 December 1999
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 52 (90001) , 107-110
Conjugated linoleic acid and the control of cancer and obesity
The effects of conjugated linoleic acid (CLA) in animals are reviewed. In most of the CLA preparations that have been investigated to date for biological activity, two CLA isomers are present in about equal concentrations: cis-9,trans-11 CLA, and trans-10,cis-12 CLA. The occurrence of these isomers in foods and their production by rumen microorganisms are discussed. Potential mechanisms of action as regards the effects of CLA on cancer and body composition are reviewed, including recent evidence that body composition changes are produced by the trans-10,cis-12 CLA isomer. Evidence is presented indicating that CLA may modulate cellular response to tumor necrosis factor-alpha (TNF-alpha). The mechanistic implications of this finding are considered.
- 1 December 1999
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 52 (90001) , 107-110
Open AccessConjugated linoleic acid and the control of cancer and obesity
The effects of conjugated linoleic acid (CLA) in animals are reviewed. In most of the CLA preparations that have been investigated to date for biological activity, two CLA isomers are present in about equal concentrations: cis-9,trans-11 CLA, and trans-10,cis-12 CLA. The occurrence of these isomers in foods and their production by rumen microorganisms are discussed. Potential mechanisms of action as regards the effects of CLA on cancer and body composition are reviewed, including recent evidence that body composition changes are produced by the trans-10,cis-12 CLA isomer. Evidence is presented indicating that CLA may modulate cellular response to tumor necrosis factor-alpha (TNF-alpha). The mechanistic implications of this finding are considered.
Evidence that the trans‐10,cis‐12 isomer of conjugated linoleic acid induces body composition changes in mice
We investigated the effects of conjugated linoleic acid (CLA) preparations, which were enriched for the cis‐9,trans‐11 CLA isomer or the trans‐10,cis‐12 CLA isomer, on body composition in mice. Body composition changes (reduced body fat, enhanced body water, enhanced body protein, and enhanced body ash) were associated with feeding the trans‐10,cis‐12 CLA isomer. In cultured 3T3‐L1 adipocytes, the trans‐10,cis‐12 isomer reduced lipoprotein lipase activity, intracellular triacylglycerol and glycerol, and enhanced glycerol release into the medium. By contrast, the cis‐9,trans‐11 and trans‐9,trans‐11 CLA isomers did not affect these biochemical activities. We conclude that CLA‐associated body composition change results from feeding the trans‐10,cis‐12 isomer.
Evidence that the trans‐10,cis‐12 isomer of conjugated linoleic acid induces body composition changes in mice
We investigated the effects of conjugated linoleic acid (CLA) preparations, which were enriched for the cis‐9,trans‐11 CLA isomer or the trans‐10,cis‐12 CLA isomer, on body composition in mice. Body composition changes (reduced body fat, enhanced body water, enhanced body protein, and enhanced body ash) were associated with feeding the trans‐10,cis‐12 CLA isomer. In cultured 3T3‐L1 adipocytes, the trans‐10,cis‐12 isomer reduced lipoprotein lipase activity, intracellular triacylglycerol and glycerol, and enhanced glycerol release into the medium. By contrast, the cis‐9,trans‐11 and trans‐9,trans‐11 CLA isomers did not affect these biochemical activities. We conclude that CLA‐associated body composition change results from feeding the trans‐10,cis‐12 isomer.
Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid
Two experiments were conducted. In Experiment 1, 8‐wk‐old mice were fed control diet or diet supplemented with 0.5% conjugated linoleic acid (CLA) to study the effect of CLA on body composition (CLA: 40.8–41.1% c‐9,t‐11 isomer, 43.5–44.9% t‐10,c‐12 isomer). The data for CLA‐fed mice vs. controls described parallel but significantly distinct responses for both absolute and relative changes in body fat mass (reduced in CLA‐fed mice) and for relative changes in whole body protein and whole body water (both of which were increased in CLA‐fed mice). In the CLA‐fed mice, the effect on whole body protein appeared to precede the reduction in body fat mass. In Experiment 2, weanling mice were fed control diet or diet supplemented with 0.5% CLA for 4 wk (test group), at which time all mice were fed control diet devoid of added CLA. The test group exhibited significantly reduced body fat and significantly enhanced whole body water relative to controls at the time of diet change. Time trends for changes in relative body composition were described by parallel lines where the test group exhibited significantly less body fat but significantly more whole body protein, whole body water, and whole body ash than controls. Tissue CLA levels declined following the withdrawal of CLA from the diet. In skeletal muscle of mice fed CLA‐supplemented diet, the t‐10,c‐12 isomer was cleared significantly faster than the c‐9,t‐11 CLA isomer.
Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid
Two experiments were conducted. In Experiment 1, 8‐wk‐old mice were fed control diet or diet supplemented with 0.5% conjugated linoleic acid (CLA) to study the effect of CLA on body composition (CLA: 40.8–41.1% c‐9,t‐11 isomer, 43.5–44.9% t‐10,c‐12 isomer). The data for CLA‐fed mice vs. controls described parallel but significantly distinct responses for both absolute and relative changes in body fat mass (reduced in CLA‐fed mice) and for relative changes in whole body protein and whole body water (both of which were increased in CLA‐fed mice). In the CLA‐fed mice, the effect on whole body protein appeared to precede the reduction in body fat mass. In Experiment 2, weanling mice were fed control diet or diet supplemented with 0.5% CLA for 4 wk (test group), at which time all mice were fed control diet devoid of added CLA. The test group exhibited significantly reduced body fat and significantly enhanced whole body water relative to controls at the time of diet change. Time trends for changes in relative body composition were described by parallel lines where the test group exhibited significantly less body fat but significantly more whole body protein, whole body water, and whole body ash than controls. Tissue CLA levels declined following the withdrawal of CLA from the diet. In skeletal muscle of mice fed CLA‐supplemented diet, the t‐10,c‐12 isomer was cleared significantly faster than the c‐9,t‐11 CLA isomer.